In Focus
-
10 Januar 2020 - Countries release genetic sequences of newly discovered coronavirus
TEM image of the hCoV-19 courtesy: IVDC, Chinese Center for Disease Control & Prevention Countries around the globe share an increasing number of hCoV-19 genome sequences
Laboratories around the world are generating in an unprecedented manner, more and more genome sequences and related clinical and epidemiological data associated with the newly emerging coronavirus (hCoV-19) rapidly made available via GISAID. The pandemic virus was first identified in late December 2019 in Hubei Province, where patients were suffering from respiratory illnesses such as pneumonia. Since then, hCoV-19 is detected across the globe.
The genome sequences of hCoV-19 are crucial to design and evaluate diagnostic tests, to track and trace the ongoing outbreak and to identify potential intervention options.
-
28 February 2020 VCM Northern Hemisphere 2020-2021
Recommended composition of influenza virus vaccines for use in the 2020-2021 Northern Hemisphere Influenza Season announced
(Geneva, Switzerland) An advisory group of experts taking part in a meeting organized by the WHO Global Influenza Programme between 24-27 February 2020 analyzed influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System (GISRS), and issued on 28 February 2020, recommendations on the composition of the influenza vaccines for the following influenza season.
These recommendations are used by the national vaccine regulatory agencies and the pharmaceutical companies to develop, produce and license influenza vaccines.
-
GISAID's Comments on the WHO Report on the Public Health Implications of Implementation of the Nagoya Protocol
-
CBD Study finds GISAID might provide useful lessons and insight to ABS discussion
CBD Study finds 'GISAID might provide useful lessons and insight to ABS discussions'
A peer-reviewed fact-finding and scoping study on digital sequence information on genetic resources in the context of the Convention on Biological Diversity and the Nagoya Protocol, highlights key advantages of GISAID’s sharing mechanism and a fair and equitable benefit-sharing resulting from access to data.
With the core principals of timely international sharing of health data for protecting populations against lethal infectious disease outbreaks and adherence to scientific etiquette of acknowledgement of the source of data has resulted in global trust and confidence in GISAID.
-
19 May 2017 G20 Health Ministers
G20 Health Ministers recognize the importance of GISAID in regard to virus data sharing
At the invitation of Germany, the first meeting of Health Ministers of the Group of Twenty leading industrialized and emerging economies (G20) took place in Berlin between 19-20 May 2017.
Under the banner of “Together Today for a Healthy Tomorrow – Joint Commitment for Shaping Global Health”, the two-day meeting focused on combating global health hazards. In their Berlin Declaration, the G20 Health Ministers recognize the importance of the Global Initiative on Sharing All Influenza Data (GISAID).
> read more
> The Berlin Declaration of the G20 Health Ministers (2017)
Free Access Credentials
Public-Private Partnerships of the GISAID Initiative
The GISAID Initiative, originally known as a Global Initiative on Sharing All Influenza Data, involves public-private-partnerships between the Initiative's administrative arm Freunde of GISAID e.V., a registered non-profit association, and governments of the Federal Republic of Germany, the official host of the GISAID platform, Singapore and the United States of America, with support from private and corporate philanthropy.
-
Congratulations to GISAID for ten years of successful work on pandemic influenza preparedness. As one of the key players in ensuring effective data sharing GISAID has made a significant contribution to global health security
Prof. Jane Halton AO PSM
Chair, Coalition for Epidemic Preparedness Innovations CEPI -
Commemorating the centenary of the 1918 pandemic, the most catastrophic event in the recorded history of influenza, it is reassuring to know that GISAID is ready and prepared when a similar event emerges and threatens global health. Congratulations on bringing together one of the most successful global collaborations ever achieved
Prof. Dr Rob Webster
St Jude Children’s Research
Hospital, Memphis, Tennessee -
The unique contribution of the GISAID data sharing mechanism is the confidence it has engendered among scientific and political communities as it has added to their capabilities to collaborate more effectively to combat influenza viruses
Dr med David Nabarro
United Nations System Coordinat.
for Avian & Human Influenza (ret) -
We do need substantially innovative mechanisms for microbe sharing, if mankind is to survive future pandemics. GISAID is an excellent example!!!
Dr Suwit Wibulpolprasert
Ministry of Public Health, Thailand
International Health Policy Program Foundation -
IFPMA acknowledges GISAID’s important role in providing the platform for the open and timely sharing of influenza data and building greater trust among countries and stakeholders, a key element to influenza global pandemic preparedness
Thomas B. Cueni
Director General
International Federation of Pharma
Manufacturers & Associations -
The tenth anniversary of GISAID represents a landmark in global solidarity. A pandemic strain of influenza is perhaps the world's greatest threat. Everything GISAID stands for: virus sharing, cutting-edge research, open access, and international cooperation to guarantee health security couldn't be more important
Prof. Lawrence O. Gostin
WHO Collaborating Center on
National and Global Health Law
Georgetown University -
GISAID’s trustworthy data sharing principles forever transformed global collaboration in the fight against influenza, enabling unprecedented rapid response to outbreaks. In 2013, Nature called China’s sharing of H7N9 avian influenza data through GISAID ‘next to exemplary’
Prof. Dr George Fu Gao
Director General
Chinese Center for Disease Control and Prevention -
The core principles enshrined in GISAID's sharing mechanism are a shining beacon of hope. A recognized leader in influenza pandemic preparedness, thanks to its brilliant performance in data sharing
Ambassador Makarim Wibisono
Republic of Indonesia (ret)
Professor, Universitas Airlangga -
A key to protecting the world from future viral threats is having immediate and open access to critical viral data. GISAID has established a highly effective, trusted and time-tested model for influenza data sharing that could serve as an important model for other viral families
Dr Dennis Carroll
Global Health Security
US Agency for International Development (USAID) -
GISAID successfully built upon the collaborative ethos of the 70-year old WHO Global Influenza Programme, to complement and extend the sharing of viruses, reagents & essential information
Dr med Wenqing Zhang
World Health Organization
Global Influenza Programme -
The GISAID Initiative was established to champion (and enhance) rapid sequence data sharing for seasonal and pandemic influenza preparedness - a global public health imperative. GISAID’s success exceeded our expectations and provides an important model for rapid data sharing for other pathogens with pandemic potential
Dr Nancy J. Cox
WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza
Centers for Disease Control and Prevention (ret) -
Not all big ideas become a reality and not all big ideas fill a global need. As a public-private partnership GISAID is a model for data sharing in the digital age. On its 10th anniversary we may look back at the initial inspiration and the headline of the supporting editorial in Nature that puts the point succinctly: Sharing saves lives
Dr med Bruce G. Gellin
Global Immunization, President
Sabin Vaccine Institute -
ECDC congratulates GISAID for a successful 10 years of advocating for and implementing sharing of influenza sequence data. The initiative plays a key role in global and European pandemic preparedness and increases our understanding of the annual influenza seasons
Dr Mike Catchpole
European Centre for Disease
Prevention and Control (ECDC) -
GISAID has advanced influenza virus data sharing to a new level, greatly contributing to the global effort to detect, respond, and mitigate seasonal and pandemic influenza
Prof. Dr med Peter Jay Hotez
Baylor College of Medicine, Dean
National School Tropical Medicine -
I congratulate the GISAID Initiative on its ten-year anniversary as it continues its important work to promote the international sharing of influenza virus sequences and data
Ambassador John E. Lange
U.S. Department of State (ret)
United Nations Foundation -
Over the past decade, GISAID has been an invaluable global partner in fostering open access to data related to influenza, a central issue related to influenza and all EIDs
Prof. Dr med Keiji Fukuda
The University of Hong Kong
School of Public Health -
GISAID encourages increased collection and rapid dissemination of data that improves our understanding of the complex and dynamic epidemiology of influenza viruses. On behalf of OFFLU network, we offer our congratulations on the contribution GISAID has made to build international collaboration over the last 10 years
Dr Peter Daniels
Dr David Swayne
OFFLU OIE/FAO Network of
Expertise on Animal Influenza -
The pioneering concept of transparent data sharing developed GISAID into the premier source of influenza virus sequence information and proven its worth in outbreak situations
Prof. Dr Thomas C. Mettenleiter
Friedrich-Loeffler-Institute
Federal Research Institute
for Animal Health, Germany -
Ten years after GISAID first introduced its game-changing mechanism, breaking data sharing barriers, it continues to be a most trusted leader in pandemic preparedness & response
Prof. Dr Yuelong Shu
Sun Yat-sen University, Dean
School of Public Health, Shenzhen -
GISAID has become the most complete public database for influenza virus sequence data in support of fundamental science and public and animal health applications
Prof. Dr Ron Fouchier
Erasmus MC Rotterdam
Viroscience & Nat'l Influenza Cntr -
By sharing influenza virus sequences among scientists around the world, GISAID has had a tremendous impact on influenza virus research
Prof. Dr Yoshihiro Kawaoka
University of Wisconsin-Madison
University of Tokyo -
The GISAID database provides access to sequences of viruses isolated less than four weeks earlier. Such timely sharing is what makes near real-time analysis possible
Prof. Dr Richard Neher
University of Basel, Biozentrum
Computational Modeling -
From the latest seasonal to new zoonotic and animal influenza viruses, GISAID always has the most relevant strains and exciting new analysis tools
Dr Sebastian Maurer-Stroh
Agency for Science, Technology
and Research A*STAR Singapore -
Open and rapid data sharing through GISAID has enabled evolutionary analysis of influenza at large-scale and in near real-time
Dr Trevor Bedford
Fred Hutchinson Cancer Research
Vaccine & Infectious Disease Div.
Genomic epidemiology of hCoV-19
COVID-19 Global Cases
